Sana Biotechnology (SANA) Competitors $4.53 +0.41 (+9.95%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$4.54 +0.01 (+0.22%) As of 05:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SANA vs. TLX, CNTA, QURE, AMRX, NAMS, XENE, CGON, RARE, VKTX, and KNSAShould you be buying Sana Biotechnology stock or one of its competitors? The main competitors of Sana Biotechnology include Telix Pharmaceuticals (TLX), Centessa Pharmaceuticals (CNTA), uniQure (QURE), Amneal Pharmaceuticals (AMRX), NewAmsterdam Pharma (NAMS), Xenon Pharmaceuticals (XENE), CG Oncology (CGON), Ultragenyx Pharmaceutical (RARE), Viking Therapeutics (VKTX), and Kiniksa Pharmaceuticals International (KNSA). These companies are all part of the "pharmaceutical products" industry. Sana Biotechnology vs. Its Competitors Telix Pharmaceuticals Centessa Pharmaceuticals uniQure Amneal Pharmaceuticals NewAmsterdam Pharma Xenon Pharmaceuticals CG Oncology Ultragenyx Pharmaceutical Viking Therapeutics Kiniksa Pharmaceuticals International Telix Pharmaceuticals (NASDAQ:TLX) and Sana Biotechnology (NASDAQ:SANA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Is TLX or SANA more profitable? Telix Pharmaceuticals' return on equity of 0.00% beat Sana Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Telix PharmaceuticalsN/A N/A N/A Sana Biotechnology N/A -91.96%-43.07% Do analysts prefer TLX or SANA? Telix Pharmaceuticals presently has a consensus target price of $21.00, indicating a potential upside of 105.08%. Sana Biotechnology has a consensus target price of $7.50, indicating a potential upside of 65.56%. Given Telix Pharmaceuticals' higher possible upside, equities analysts clearly believe Telix Pharmaceuticals is more favorable than Sana Biotechnology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telix Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Sana Biotechnology 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media prefer TLX or SANA? In the previous week, Telix Pharmaceuticals had 5 more articles in the media than Sana Biotechnology. MarketBeat recorded 8 mentions for Telix Pharmaceuticals and 3 mentions for Sana Biotechnology. Telix Pharmaceuticals' average media sentiment score of 0.75 beat Sana Biotechnology's score of 0.00 indicating that Telix Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Telix Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sana Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, TLX or SANA? Telix Pharmaceuticals has higher revenue and earnings than Sana Biotechnology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelix Pharmaceuticals$516.72M6.71$32.93MN/AN/ASana BiotechnologyN/AN/A-$266.76M-$1.06-4.27 Do institutionals and insiders believe in TLX or SANA? 88.2% of Sana Biotechnology shares are held by institutional investors. 30.1% of Sana Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryTelix Pharmaceuticals beats Sana Biotechnology on 8 of the 11 factors compared between the two stocks. Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SANA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SANA vs. The Competition Export to ExcelMetricSana BiotechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$979.76M$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-4.2721.5785.3527.60Price / SalesN/A271.49539.78202.41Price / CashN/A47.1237.9261.55Price / Book4.0410.1413.016.76Net Income-$266.76M-$52.31M$3.30B$275.88M7 Day Performance14.11%5.14%4.34%2.81%1 Month Performance50.00%14.68%9.49%9.24%1 Year Performance13.53%30.98%84.83%35.42% Sana Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SANASana Biotechnology2.5912 of 5 stars$4.53+10.0%$7.50+65.6%+11.0%$979.76MN/A-4.27380Analyst ForecastTLXTelix Pharmaceuticals4.4741 of 5 stars$9.89-0.9%$21.00+112.3%N/A$3.35B$637.77M0.00N/AAnalyst UpgradeHigh Trading VolumeCNTACentessa Pharmaceuticals3.035 of 5 stars$24.40+4.9%$32.38+32.7%+38.7%$3.27B$15M-13.63200Analyst ForecastQUREuniQure3.5331 of 5 stars$59.40+9.4%$67.17+13.1%+913.0%$3.26B$27.12M-15.15500Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeAMRXAmneal Pharmaceuticals2.7863 of 5 stars$9.87+1.2%$12.00+21.6%+21.0%$3.10B$2.79B987.998,100Analyst ForecastNAMSNewAmsterdam Pharma3.1863 of 5 stars$27.52-3.4%$42.00+52.6%+85.2%$3.10B$45.56M-16.994Analyst ForecastXENEXenon Pharmaceuticals2.892 of 5 stars$39.06+2.8%$53.30+36.5%-4.3%$3.01B$9.43M-11.00210Trending NewsAnalyst ForecastAnalyst RevisionCGONCG Oncology2.3155 of 5 stars$39.08+4.1%$56.55+44.7%+16.9%$2.98B$1.14M-22.0861Analyst ForecastGap UpRAREUltragenyx Pharmaceutical4.387 of 5 stars$30.36+4.4%$81.50+168.4%-42.1%$2.93B$560.23M-5.491,294Analyst ForecastVKTXViking Therapeutics4.0124 of 5 stars$25.81+0.9%$86.42+234.8%-51.5%$2.90BN/A-16.8720Analyst ForecastGap UpKNSAKiniksa Pharmaceuticals International3.649 of 5 stars$38.77+6.2%$44.29+14.2%+56.6%$2.87B$423.24M969.49220Analyst Downgrade Related Companies and Tools Related Companies TLX Competitors CNTA Competitors QURE Competitors AMRX Competitors NAMS Competitors XENE Competitors CGON Competitors RARE Competitors VKTX Competitors KNSA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SANA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
